UnitedHealth Group Incorporated $UNH Holdings Boosted by Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A.

Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. grew its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 4.8% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 8,168 shares of the healthcare conglomerate’s stock after purchasing an additional 375 shares during the quarter. Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A.’s holdings in UnitedHealth Group were worth $2,548,000 as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. Bayforest Capital Ltd lifted its stake in UnitedHealth Group by 685.7% in the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after buying an additional 48 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd boosted its stake in UnitedHealth Group by 416.7% during the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock valued at $32,000 after purchasing an additional 50 shares during the period. IAG Wealth Partners LLC acquired a new stake in shares of UnitedHealth Group in the first quarter valued at approximately $42,000. O Brien Wealth Partners LLC raised its holdings in shares of UnitedHealth Group by 74.0% during the first quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate’s stock valued at $46,000 after buying an additional 37 shares during the last quarter. Finally, Kentucky Trust Co grew its holdings in UnitedHealth Group by 138.5% in the 1st quarter. Kentucky Trust Co now owns 93 shares of the healthcare conglomerate’s stock worth $49,000 after buying an additional 54 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $354.30 on Friday. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The company has a market capitalization of $320.88 billion, a PE ratio of 15.35, a price-to-earnings-growth ratio of 2.29 and a beta of 0.47. The stock has a fifty day moving average of $318.21 and a 200-day moving average of $349.25. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). The company had revenue of $111.62 billion for the quarter, compared to analysts’ expectations of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company’s revenue for the quarter was up 12.9% on a year-over-year basis. During the same period in the prior year, the company earned $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were given a $2.21 dividend. This represents a $8.84 annualized dividend and a dividend yield of 2.5%. The ex-dividend date was Monday, September 15th. UnitedHealth Group’s dividend payout ratio is 38.30%.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on UNH shares. Oppenheimer decreased their price target on UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating for the company in a research note on Wednesday, July 30th. Robert W. Baird reissued an “underperform” rating and set a $198.00 target price (down previously from $312.00) on shares of UnitedHealth Group in a research note on Thursday, July 31st. Mizuho upped their price target on shares of UnitedHealth Group from $300.00 to $430.00 and gave the stock an “outperform” rating in a research note on Thursday. Barclays upped their target price on UnitedHealth Group from $352.00 to $386.00 and gave the stock an “overweight” rating in a research report on Thursday. Finally, Royal Bank Of Canada dropped their price objective on UnitedHealth Group from $355.00 to $286.00 and set an “outperform” rating on the stock in a research note on Wednesday, July 30th. Sixteen investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and four have given a Sell rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $383.09.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.